These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17340625)

  • 1. The catalytically inactive precursor of cathepsin D induces apoptosis in human fibroblasts and HeLa cells.
    Schestkowa O; Geisel D; Jacob R; Hasilik A
    J Cell Biochem; 2007 Aug; 101(6):1558-66. PubMed ID: 17340625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stress-induced apoptosis is impaired in cells with a lysosomal targeting defect but is not affected in cells synthesizing a catalytically inactive cathepsin D.
    Tardy C; Tyynelä J; Hasilik A; Levade T; Andrieu-Abadie N
    Cell Death Differ; 2003 Sep; 10(9):1090-100. PubMed ID: 12934083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microinjection of cathepsin d induces caspase-dependent apoptosis in fibroblasts.
    Roberg K; Kågedal K; Ollinger K
    Am J Pathol; 2002 Jul; 161(1):89-96. PubMed ID: 12107093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha.
    Deiss LP; Galinka H; Berissi H; Cohen O; Kimchi A
    EMBO J; 1996 Aug; 15(15):3861-70. PubMed ID: 8670891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of cathepsin D prevents free-radical-induced apoptosis in rat cardiomyocytes.
    Ollinger K
    Arch Biochem Biophys; 2000 Jan; 373(2):346-51. PubMed ID: 10620358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catalytically inactive human cathepsin D triggers fibroblast invasive growth.
    Laurent-Matha V; Maruani-Herrmann S; Prébois C; Beaujouin M; Glondu M; Noël A; Alvarez-Gonzalez ML; Blacher S; Coopman P; Baghdiguian S; Gilles C; Loncarek J; Freiss G; Vignon F; Liaudet-Coopman E
    J Cell Biol; 2005 Jan; 168(3):489-99. PubMed ID: 15668295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calculating proton uptake/release and binding free energy taking into account ionization and conformation changes induced by protein-inhibitor association: application to plasmepsin, cathepsin D and endothiapepsin-pepstatin complexes.
    Alexov E
    Proteins; 2004 Aug; 56(3):572-84. PubMed ID: 15229889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of procathepsin D from mature cathepsin D by pepstatin affinity chromatography. Autocatalytic proteolysis of the zymogen form of the enzyme.
    Conner GE
    Biochem J; 1989 Oct; 263(2):601-4. PubMed ID: 2512908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled production of active cathepsin D in retinal pigment epithelial cells following adenovirus-mediated gene delivery.
    Lai CM; Robertson T; Papadimitriou J; Shen WY; Daw N; Constable IJ; Rakoczy PE
    Mol Ther; 2000 Nov; 2(5):476-84. PubMed ID: 11082321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cathepsin D inhibitor from Vicia sativa L. seed hulls on human skin fibroblasts and breast cancer cells (in vitro studies).
    Roszkowska-Jakimiec W; Wołczyński S; Chlabicz M
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():234-5. PubMed ID: 15638434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory cytokines increase extracellular procathepsin D in permanent and primary endothelial cell cultures.
    Erdmann S; Ricken A; Hummitzsch K; Merkwitz C; Schliebe N; Gaunitz F; Strotmann R; Spanel-Borowski K
    Eur J Cell Biol; 2008 May; 87(5):311-23. PubMed ID: 18387691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of both catalytically active and -inactive cathepsin D by cancer cells enhances apoptosis-dependent chemo-sensitivity.
    Beaujouin M; Baghdiguian S; Glondu-Lassis M; Berchem G; Liaudet-Coopman E
    Oncogene; 2006 Mar; 25(13):1967-73. PubMed ID: 16331270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cathepsin D propeptide: mechanism and regulation of its interaction with the catalytic core.
    Mása M; Maresová L; Vondrásek J; Horn M; Jezek J; Mares M
    Biochemistry; 2006 Dec; 45(51):15474-82. PubMed ID: 17176069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High yield synthesis and characterization of phosphorylated recombinant human procathepsin D expressed in mammalian cells.
    Démoz M; Castino R; Follo C; Hasilik A; Sloane BF; Isidoro C
    Protein Expr Purif; 2006 Jan; 45(1):157-67. PubMed ID: 16242956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of lysosomal storage-induced p38 MAP kinase activation in the overproduction of nitric oxide by microglia in cathepsin D-deficient mice.
    Yamasaki R; Zhang J; Koshiishi I; Sastradipura Suniarti DF; Wu Z; Peters C; Schwake M; Uchiyama Y; Kira J; Saftig P; Utsumi H; Nakanishi H
    Mol Cell Neurosci; 2007 Aug; 35(4):573-84. PubMed ID: 17570679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cathepsin D released by lactating rat mammary epithelial cells is involved in prolactin cleavage under physiological conditions.
    Lkhider M; Castino R; Bouguyon E; Isidoro C; Ollivier-Bousquet M
    J Cell Sci; 2004 Oct; 117(Pt 21):5155-64. PubMed ID: 15456852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cathepsin D overexpressed by cancer cells can enhance apoptosis-dependent chemo-sensitivity independently of its catalytic activity.
    Beaujouin M; Liaudet-Coopman E
    Adv Exp Med Biol; 2008; 617():453-61. PubMed ID: 18497069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fucoidan by inhibiting cathepsin D activities alleviates PC12 apoptosis induced by hydrogen peroxide].
    Zhang G; Li P; Li Y; Liu X; Chen Y; Weng X; Yang Q; Zhu X
    Zhongguo Zhong Yao Za Zhi; 2011 Apr; 36(8):1083-6. PubMed ID: 21809591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteolysis of cystatin C by cathepsin D in the breast cancer microenvironment.
    Laurent-Matha V; Huesgen PF; Masson O; Derocq D; Prébois C; Gary-Bobo M; Lecaille F; Rebière B; Meurice G; Oréar C; Hollingsworth RE; Abrahamson M; Lalmanach G; Overall CM; Liaudet-Coopman E
    FASEB J; 2012 Dec; 26(12):5172-81. PubMed ID: 22898924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based subsite specificity mapping of human cathepsin D using statine-based inhibitors.
    Majer P; Collins JR; Gulnik SV; Erickson JW
    Protein Sci; 1997 Jul; 6(7):1458-66. PubMed ID: 9232647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.